IXHL
NASDAQ
$3.21
Incannex Healthcare Inc (IXHL)
Incannex Healthcare Limited is engaged in the research, development and sale of medicinal cannabinoid products in Australia. The company is headquartered in Sydney, Australia.
Sector:
Healthcare
Target: $17.78 (+453.89%)
Market Cap
$44M
P/B Ratio
0.51
Free Cash Flow Yield
-40.13%
Beta (5Y)
0.32
Price Chart
Valuation
Market Cap$44M
Forward P/E3.78
P/S7764.11
P/B0.51
Profitability
Gross Profit (TTM)$12K
EBITDA-$26M
EPS-$6.26
Financial Health
Free Cash Flow Yield-40.13%
Growth & Risk
Beta (5Y)0.32
Sharpe Ratio0.12